Transurethral versus transvesical prostatectomy. Physiological strain
- PMID: 2414844
- DOI: 10.3109/00365598509180232
Transurethral versus transvesical prostatectomy. Physiological strain
Abstract
The present randomized study evaluated the physiological strain in transurethral (TURP) versus transvesical (TVP) prostatectomy in 75 patients with clinically benign, medium-sized prostatic enlargement. In both groups 5 patients had coincidental prostatic carcinoma. During TURP a suprapubic trocar was inserted for irrigation with 1.5% glycine. Antibiotics were given to patients with preoperative urinary tract infection and postoperatively tranexamic acid was administered to all patients. Coexisting diseases which might increase the operative risk were equally present in TURP and TVP patients. No patient died in connection with the operative procedures. Median duration of anaesthesia for TVP was 95 min and for TURP 60 min (p less than 0.001). Almost identical operative blood loss was seen in the two groups. However, more blood transfusion were given to TVP patients. Following discharge, more episodes of bleeding were registered in the TURP group, but no significant difference was observed in number of secondary operations for bleeding. In the TVP group, more patients had pulmonary complications, elevated rectal temperature as well as antibiotic treatment and 34% of these patients developed wound infection. Secondary operations before discharge were also more frequently undertaken in TVP patients. No differences between the two groups were seen pre- or postoperatively with respect to electrolyte, protein, creatinine and haemoglobin values. In the patients with incidental prostatic carcinoma a TURP was the most gentle procedure. With respect to physiological strain a TURP is clearly to be preferred over a TVP for obstructive clinically benign, medium-sized prostatic hyperplasia.
Similar articles
-
Clinical evaluation of transurethral versus transvesical prostatectomy. A randomized study.Scand J Urol Nephrol. 1984;18(3):201-9. doi: 10.3109/00365598409180184. Scand J Urol Nephrol. 1984. PMID: 6208603
-
Economy in transurethral prostatectomy.Scand J Urol Nephrol. 1985;19(1):17-20. doi: 10.3109/00365598509180216. Scand J Urol Nephrol. 1985. PMID: 2410979 Clinical Trial.
-
Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients.Eur Urol. 1998;33(4):359-64. doi: 10.1159/000019616. Eur Urol. 1998. PMID: 9612677 Clinical Trial.
-
Recent developments in the surgical management of benign prostatic hyperplasia.Urology. 1998 Apr;51(4A Suppl):23-31. doi: 10.1016/s0090-4295(98)00052-1. Urology. 1998. PMID: 9586593 Review.
-
[Complications of transurethral operations].Anesteziol Reanimatol. 1985 Jul-Aug;(4):69-74. Anesteziol Reanimatol. 1985. PMID: 2415025 Review. Russian. No abstract available.
Cited by
-
Transurethral resection of very large prostates. A retrospective study.Int Urol Nephrol. 1991;23(3):245-50. doi: 10.1007/BF02550419. Int Urol Nephrol. 1991. PMID: 1716246
-
A Retrospective Operative and Early Outcome Comparison of Suprapubic Transvesical Prostatectomy and Transurethral resection of the Prostate.Ethiop J Health Sci. 2021 Jul;31(4):785-792. doi: 10.4314/ejhs.v31i4.13. Ethiop J Health Sci. 2021. PMID: 34703178 Free PMC article.
-
Benign prostatic hyperplasia and its treatment.J Gen Intern Med. 1990 Mar-Apr;5(2):153-65. doi: 10.1007/BF02600518. J Gen Intern Med. 1990. PMID: 1690275 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical